MYTH BUSTER

Common Supplement Manufacturing Myths Debunked: Separating Fact from Fiction

Separating reality from hearsay in B2B manufacturing: Are massive MOQs mandatory? Does domestic manufacturing always outperform overseas cGMP certified facilities? We break down the real economics.

KF
Konnor Formulation Desk
cGMP Cleanroom Operations & Analytical Testing
Sep 29, 2026
6 min read
Common Supplement Manufacturing Myths Debunked: Separating Fact from Fiction
FACTS VS. MYTHS IN MANUFACTURINGMOQ Flexibility • Certified Testing Integrity • Lead Time Realities
Executive 30-Second Formulation Takeaway

Brand founders frequently hear persistent rumors regarding minimum order quantities, testing standards, and foreign facility compliance.

1. Myth: "You Need 50,000 Bottles to Get Started"

Fact: Modern lean manufacturing lines and flexible automated packaging allow pilot runs starting as low as 500 to 1,000 bottles.

2. Myth: "Overseas Facilities Cannot Meet US FDA cGMP"

Fact: Konnor operates under strict FDA 21 CFR 111 cGMP regulations with registered FEI facility numbers, verified third-party ISO 17025 testing, and complete export documentation.

Back to All Lab Notes & BlogKonnor Health cGMP Formulation Desk
Factory Contract Manufacturing Capabilities

Turnkey Production & Finished Product Catalogs

Direct Formulator Consultation

Have a Question About This Formulation Note?

Connect directly with our senior formulation chemists on WhatsApp to review active ingredient load limits, evaluate pilot stability reports, or request commercial pilot evaluation samples.

Request Custom Evaluation

Request Formulation Dossier & Commercial Quotation

Fast B2B Commercial Inquiry Desk

Request Formulation Dossier & Custom Quote (20 Seconds)

Bilateral NDA Protected
Zero Spam Policy • Standard Commercial Evaluation Sampling Available